Skip to main content
    C

    Cardiol Therapeutics Inc Class A (CRDL)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $0.98
    -0.02 (-2.02%)

    Market Cap: $127.69M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Cardiol Therapeutics Inc Class A (CRDL) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cardiol Therapeutics Inc Class A are Akebia Ther (AKBA), Cumberland Pharmaceuticals (CPIX) and Lifecore Biomedical (LFCR). By market cap, Cardiol Therapeutics Inc Class A ranks 7th of the 13 companies on this page; Tilray (TLRY) is the largest at $359.12M.

    Peer Comparison

    CRDL's revenue growth of 0.0% is above the peer median of -9.3%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cardiol Therapeutics Inc Class A (CRDL)$127.69MN/AN/A0.0%N/A0.0%0.00%
    Akebia Ther (AKBA)$131.67MN/A0.6x-22.6%-38.9%-37.2%0.00%
    Cumberland Pharmaceuticals Inc (CPIX)$88.16MN/A3.1x148.6%N/A-74.0%28.79%
    Lifecore Biomedical Inc. (LFCR)$243.36MN/AN/A-66.8%N/A-18.6%0.00%
    Journey Medical Corp (DERM)$122.24MN/A1.5x-7.3%-2.8%7.6%0.00%
    Anika Therapeutics Inc (ANIK)$179.50M18.7x1.4x-1.4%N/A10.0%0.00%
    Organogenesis Holdings Inc (ORGO)$105.15MN/A0.3x-38.5%-66.3%-69.9%0.00%
    OrganiGram Holdings Inc (OGI)$116.93MN/A0.4x28.0%-1.2%49.4%0.00%
    SIGA Technologies Inc (SIGA)$196.88M475.0xN/A1.3%N/A-49.7%0.00%
    Tilray Inc (TLRY)$359.12MN/A0.3x-17.1%-4.9%22.7%0.00%
    Talphera Inc. (TLPH)$47.07MN/AN/A0.0%N/A0.0%0.00%
    BioAge Labs, Inc (BIOA)$255.03MN/A27.9x0.0%N/A-85.5%0.00%
    InterCure Ltd. (INCR)$49.17MN/AN/A-13.2%N/A23.9%0.00%
    Peer median$126.95M246.9x1.0x-4.4%-4.9%-9.3%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cardiol Therapeutics Inc Class A, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Drug Manufacturers - Specialty & Generic.

    CompanyAboutPeers
    Akebia Ther (AKBA)
    Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of kidney therapies for patients with kidney disease.
    AKBA competitors
    Cumberland Pharmaceuticals Inc (CPIX)
    Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development...
    CPIX competitors
    Lifecore Biomedical Inc. (LFCR)
    Lifecore Biomedical, Inc., is an integrated contract development and manufacturing organization in the United States and internationally.
    LFCR competitors
    Journey Medical Corp (DERM)
    Dermira, Inc., a biopharmaceutical company, develops and markets therapies for patients with dermatological diseases in the United States.
    DERM competitors
    Anika Therapeutics Inc (ANIK)
    Anika Therapeutics, Inc., is a joint preservation company in the United States, Europe, and internationally.
    ANIK competitors
    Organogenesis Holdings Inc (ORGO)
    Organogenesis Holdings Inc., a regenerative medicine company, develops, manufactures and markets solutions for the advanced wound care and surgical and sports...
    ORGO competitors
    OrganiGram Holdings Inc (OGI)
    Organigram Holdings Inc. produces and sells cannabis and cannabis-derived products in Canada. The company is headquartered in Moncton, Canada.
    OGI competitors
    SIGA Technologies Inc (SIGA)
    SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health safety and infectious disease markets in the United States.
    SIGA competitors
    Tilray Inc (TLRY)
    Tilray Inc. is dedicated to the research, cultivation, production and distribution of medicinal cannabis and cannabinoids.
    TLRY competitors
    Talphera Inc. (TLPH)
    Talphera Inc. is a pioneering biotechnology company dedicated to advancing peptide-based therapies for rare diseases and significant unmet medical needs.
    TLPH competitors
    BioAge Labs, Inc (BIOA)
    BioAmber Inc., an industrial biotechnology company, produces and sells bio-succinic acid to various customers in the chemical market primarily in the United...
    BIOA competitors
    InterCure Ltd. (INCR)
    Syneos Health, Inc., a contract research organization, provides various clinical development services for the medical device and biopharmaceutical industries...

    Frequently Asked Questions About CRDL

    Who are Cardiol Therapeutics Inc Class A's main competitors?

    The companies most similar to Cardiol Therapeutics Inc Class A include Akebia Ther (AKBA), Cumberland Pharmaceuticals (CPIX), Lifecore Biomedical (LFCR), Journey Medical (DERM) and Anika Therapeutics (ANIK), listed from the closest match.

    Who is Cardiol Therapeutics Inc Class A's biggest competitor?

    Tilray (TLRY) is the largest of the similar companies at $359.12M; Akebia Ther (AKBA) is the closest match by business profile, size, sector and industry.

    How does CRDL stock compare with its competitors?

    CRDL's net margin is 0.0% against a peer median of -4.4%.

    Which of Cardiol Therapeutics Inc Class A's competitors pays a higher dividend?

    Cardiol Therapeutics Inc Class A pays no dividend. Cumberland Pharmaceuticals (CPIX) has a higher forward dividend yield; Cumberland Pharmaceuticals (CPIX) has the highest at 28.79%.

    Is Cardiol Therapeutics Inc Class A bigger than its competitors?

    No. Cardiol Therapeutics Inc Class A is 7th by market cap among the 13 companies on this page; the largest is Tilray (TLRY) at $359.12M.